Community Liver Alliance: 2021 Liver Cancer Conference

October 30, 2021

The goal of this course module is to help clinicians and other service providers understand the management of Hepatocellular Carcinoma in the US population, innovations in therapies and advances in research and development.

Target Audience

This program is directed to providers, patients and caregivers. Concurrent educational sessions will be held for hepatologists, gastroenterologists, oncologists, primary care physicians and other health care providers involved in the management of patients with liver cancer. A separate session will be geared towards patients and their caregivers.

Learning Objectives

At course completion, attendees should be able to:

Increase Knowledge 

  • Understand the molecular classification of HCC
  • Understand the multidisciplinary approach to management of HCC


Competency

  • Define the mechanisms that lead to the development of hepatocellular cancer (HCC)


Performance

  • Discuss the available evidence-based data on promising treatment options for advanced HCC
  • Discuss the advances in research and development

Additional Information

Course summary
Available credit: 
  • 4.75 AAPA Category I CME
  • 4.75 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 4.75 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 4.75 Attendance
Course opens: 
10/30/2021
Course expires: 
12/31/2021
Event starts: 
10/30/2021 - 8:15am
Event ends: 
10/30/2021 - 2:00pm

Schedule:

8:15-8:30 a.m. Welcome and Overview 
Dulabh K Monga, MD and Satdarshan (Paul) Monga, MD Course Directors 
Suzanna Masartis  
CEO, Community Liver Alliance 

8:30-9:00 a.m. How Does Liver Cancer Develop? 
Satdarshan (Paul) Monga, MD 
Professor and Vice Chair of Pathology 
Director, Pittsburgh Liver Research Center, 
University of Pittsburgh and UPMC 

9:00-9:30 a.m. HCC Surveillance in High Risk Liver Cancer Obaid Shaikh, MD 
Director, Transplant Medicine 
Professor, Division of Gastroenterology, Hepatology and Nutrition UPMC 
9:30-10:00 a.m. Role of Surgical Resection and Transplantation in HCC Management  
David Geller, MD 
Director, UPMC Liver Cancer Center 

10:00-10:30 a.m. Concurrent Session 
Role of Locoregional Therapies in HCC Management Andrew Klobuka, MD 
Department of Radiology,  
Allegheny Health Network 
Patient Roundtable Discussion 
Brittany Morocco, MPAS, PA-C 
Senior Physician Assistant 
UPMC Liver Cancer Center 

10:30-11:00 a.m. Medical Management of HCC 
Dulabh K Monga, MD 
Program Director, Hematology Oncology Fellowship 
Assistant Professor of Medicine 
Allegheny Health Network 

11:00 a.m. – 11:30 a.m. Radiation Therapy for HCC 
Paul Renz, DO 
Radiation Oncology Specialist 
Allegheny Health Network 

11:30 am to 12:00 p.m. State of the Art in Intrahepatic Cholangiocarcinoma: Diagnosis and Treatment  
Mitesh Borad, MD 
Associate Professor of Medicine  
Consultant, Division of Hematology/Oncology,  
Department of Internal Medicine, 
Mayo Clinic 

12:00-12:30 p.m. Lunch Break 

12:30-1:00 p.m. Sponsor Exhibit Visits 

1:00-1:45 p.m. Case Presentations Resectable/Transplantable HCC  
Dheera Reddy, MD 
UPMC 
Non-Resectable Non-Transplantable HCC and Medical and Locoregional Options  
Alex Helfand, MD 
Allegheny Health Network 
Intrahepatic Cholangiocarcinoma 
Jiaxiang Liu, MD 
Allegheny Health Network 

1:45-2:00 p.m. Case Presentation Q&A 
Moderator: Suzanna Masartis 

2:00 P.M. Adjournment

Live Virtual Program
Pittsburgh
United States

Course Directors:
Dulabh K. Monga, MD
Program Director
Hematology Oncology Fellowship
Assistant Professor of Medicine
Temple University School of Medicine
Allegheny Health Network
Pittsburgh, PA

Satdarshan (Paul) Singh Monga, MD
UPMC Endowed Chair for Experimental Pathology
Professor of Pathology and Medicine
Director, Pittsburgh Liver Research Center,
Chief and Vice Chair, Division of Experimental Pathology
University of Pittsburgh, School of Medicine and UPMC
Pittsburgh, PA

Faculty Listing
Dulabh K. Monga, MD
Program Director
Hematology Oncology Fellowship
Assistant Professor of Medicine
Temple University School of Medicine
Allegheny Health Network
Pittsburgh, PA

Satdarshan (Paul) Singh Monga, MD
UPMC Endowed Chair for Experimental Pathology
Professor of Pathology and Medicine
Director, Pittsburgh Liver Research Center,
Chief and Vice Chair, Division of Experimental Pathology
University of Pittsburgh, School of Medicine and UPMC
Pittsburgh, PA

David Geller, MD
Director
UPMC Liver Cancer Center
Pittsburgh, PA

Andrew Klobuka, MD
Department of Radiology
Allegheny Health Network
Pittsburgh, PA

Brittany Morocco, PA-C
Senior Physician Assistant
UPMC Liver Cancer Center
Pittsburgh, PA

Suzanna Masartis,
CEO
Community Liver Alliance
Pittsburgh, PA

Paul Renz, DO
Radiotherapy Therapy for Hepatocellular Carcinoma
Allegheny Health Network
Pittsburgh, PA

Mitesh Borad, MD
Associate Professor of Medicine Consultant, Division of Hematology/Oncology, Department of Internal
Medicine
Consultant, Department of Molecular Medicine
Mayo Clinic
Scottsdale, AZ

Obaid Shaikh, MD
Director, Transplant Medicine
Professor, Division of Gastroenterology, Hepatology and Nutrition
UPMC

Continuing Education Credit
In support of improving patient care, this activity has been planned and implemented by the University of Pittsburgh and Community Liver Alliance. The University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician (CME)
The University of Pittsburgh designates this live activity for a maximum of 4.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing (CNE)
The maximum number of hours awarded for this Continuing Nursing Education activity is 4.75 contact hours.

Physician Assistant (AAPA)
The University of Pittsburgh has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 4.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Available Credit

  • 4.75 AAPA Category I CME
  • 4.75 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 4.75 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 4.75 Attendance
Please login or register to take this course.

Please contact Suzanna Masartis by email at suzanna@communityliveralliance.org if you have any questions.